Biosimilars on LASA list

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Fri, 05/06/2022 - 09:04
#1
Steven Jarrett
Steven Jarrett's picture
Offline
Last seen: 4 months 3 weeks ago
Joined: 11/06/2012 - 14:32
Biosimilars on LASA list

Good Morning -

We are combining lists for LASA as we integrate as a System. One of the discussion points is the addition of Biosimilars to the list. For the most part we are using the naming as generic (brand) for these agents when character limits allow.

Have others added these to the LASA list or as a separate list within the policy?

Do you do all the available agents or just the ones on formulary.

Thanks

Top